Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple sclerosis: Repurposing dopaminergic drugs for MS - the evidence mounts.
Automated White Matter Hyperintensity Detection in Multiple Sclerosis Using 3D T2 FLAIR.
Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis: From the Safety Assessment of Biologic ThERapy (SABER) Study.
A Friend in Need may not be a Friend Indeed: Role of Microglia in Neurodegenerative Diseases.
[Consensus document on spasticity in patients with multiple sclerosis.]
Dual diagnosis: rheumatoid arthritis and multiple sclerosis.
Slowed Exercise-Onset Vo2 Kinetics During Submaximal Endurance Exercise in Subjects With Multiple Sclerosis.
Examining Trait Mindfulness, Emotion Dysregulation, and Quality of Life in Multiple Sclerosis.
Pathological Involvement of Astrocyte-Derived Lipocalin-2 in the Demyelinating Optic Neuritis.
IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.
Smoking as a risk factor for multiple sclerosis.
Oxidative stress and neurodegenerative disease.
Clinical outcomes in multiple sclerosis patients following venous angioplasty.
Prediction of disease severity in neuromyelitis optica by the levels of IL-6 produced during remission phase.
Myocarditis and diffuse skeletal muscle oedema: new features of neuromyelitis optica spectrum disorder? A case report.
Alpha-B-crystallin induces an immune-regulatory and antiviral microglial response in preactive multiple sclerosis lesions.
The prevalence of urinary catheterization in women and men with multiple sclerosis.
Long-term endurance exercise improves aerobic capacity in patients with relapsing-remitting Multiple Sclerosis: Impact of baseline fatigue.
First-ever optic neuritis: distinguishing subsequent neuromyelitis optica from multiple sclerosis.
Walking while talking in patients with multiple sclerosis: The impact of specific cognitive loads.
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE.
Association between IRF5 polymorphisms and autoimmune diseases: a meta-analysis.
Individualized rituximab treatment for relapsing neuromyelitis optica: a pediatric case report.
T-cell reactivity against AQP4 in neuromyelitis optica.
Antibodies to MOG in NMO: A seasoned veteran finds a new role.

Pages